Saying she is “disappointed, saddened and deeply concerned” by, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.
Parker, whose 13-year-old son James has severe peanut and hazelnut, was part of a short campaign with pharmaceutical giant Mylan N.V., maker of the EpiPen, to raise awareness about anaphylaxis, a life-threatening allergic reaction. She was never a spokeswoman for the product.
Mylan is facing heated criticism after the list price of an EpiPen twin-pack climbed to $608 over the past nine years, up from about $93.
The company announced Thursday that it would demanding further action.to reduce or eliminate some consumers’ out-of-pocket expenses, but some members of Congress are
Parker took to Instagram on Thursday to announce that “I have ended my relationship with Mylan as a direct result” of its pricing decisions.
She urged the company to “take swift action to lower the cost to be more affordable for whom it is a life-saving necessity.”